Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Vitreoretinal Diseases and Surgery
How do you incorporate intravitreal methotrexate injections into the management of traumatic retinal detachment repairs?
Related Questions
What factors influence your evaluation of surgical candidacy for persistent fetal vasculature, and how do you approach operative management?
How do you manage cystoid macular edema (CME) in patients with steroid-induced intraocular hypertension that is resistant to topical treatments?
What factors guide your decision to perform subretinal fluid drainage during primary scleral buckle surgery for a rhegmatogenous retinal detachment?
In your experience, what factors prompt you to switch a patient with diabetic macular edema to Eylea HD?
In which cases of post-injection endophthalmitis should early vitrectomy be considered if there is little to no improvement 48 hours after a tap and inject and there is no organism isolated?
How should diabetic retinopathy surveillance be adjusted for patients starting GLP-1 agonists?
What long-term complications have you observed in previously stable preterm infants with incomplete peripheral retinal vascularization who did not undergo ROP laser treatment?
What factors guide the decision to treat with ROP laser treatment versus a repeat anti-VEGF injection in a child who has previously received anti-VEGF therapy for retinopathy of prematurity (ROP)?
What factors guide the choice between early versus delayed vitrectomy after an open globe injury?
When should delayed removal of an intraocular foreign body be considered?
